✦ LIBER ✦

Correlation of YMDD mutation and breakthrough hepatitis with hepatitis B virus DNA and serum ALT during lamivudine treatment

✍ Scribed by Mariko Kobayashi; Fumitaka Suzuki; Norio Akuta; Hiromi Yatsuji; Tetsuya Hosaka; Hitomi Sezaki; Masahiro Kobayashi; Yusuke Kawamura; Yoshiyuki Suzuki; Yasuji Arase; Kenji Ikeda; Rie Mineta; Satomi Iwasaki; Sachiyo Watahiki; Hiromitsu Kumada

Book ID: 118088188
Publisher: John Wiley and Sons
Year: 2010
Tongue: English
Weight: 377 KB
Volume: 40
Category: Article
ISSN: 1386-6346
DOI: 10.1111/j.1872-034x.2009.00565.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Acute exacerbation and hepatitis B virus

Acute exacerbation and hepatitis B virus clearance after emergence of YMDD motif mutation during lamivudine therapy

✍ Yun-Fan Liaw; Rong-Nan Chien; Chau-Ting Yeh; Sun-Lung Tsai; Chia-Ming Chu 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 77 KB 👁 1 views

Lamivudine is a potent inhibitor of hepatitis B virus (HBV) replication, but its long-term use may be associated with HBV tyrosine-methionine-aspartate-aspartate (YMDD) motif mutation. To examine the clinical features and course after emergence of YMDD mutants, 55 patients who received lamivudine th

Emergence of YMDD motif mutants of hepat

Emergence of YMDD motif mutants of hepatitis B virus during lamivudine treatment of immunocompetent type B hepatitis patients

✍ Seta, Toshikatsu; Yokosuka, Osamu; Imazeki, Fumio; Tagawa, Masami; Saisho, Hirom 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 174 KB 👁 2 views

Lamivudine is an effective antiviral agent for the treatment of chronic type B hepatitis. Recent studies have shown the appearance of lamivudine resistant viruses with mutations at the tyrosine-methionine-aspartate-aspartate (YMDD) motif of the viral polymerase in hepatitis B virus (HBV) infected pa

Clinical outcomes of chronic hepatitis B

Clinical outcomes of chronic hepatitis B patients with persistently detectable serum hepatitis B virus DNA during lamivudine therapy

✍ Ji H Kim; Sang K Yu; Yeon S Seo; Hyung J Yim; Jong E Yeon; Jong J Park; Jae S Ki 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 231 KB

Correlation of the occurrence of YMDD mu

Correlation of the occurrence of YMDD mutations with HBV genotypes, HBV-DNA levels, and HBeAg status in Chinese patients with chronic hepatitis B during lamivudine treatment

✍ Feng Wu; Min-Jin Wu; Xiao-Lin Zhuge; Shao-Ming Zhu; Biao Zhu 📂 Article 📅 2012 🏛 Zhejiang University School of Medicine, China 🌐 English ⚖ 111 KB

Differences of YMDD mutational patterns,

Differences of YMDD mutational patterns, precore/core promoter mutations, serum HBV DNA levels in lamivudine-resistant hepatitis B genotypes B and C

✍ X. P. Pan; L. J. Li; W. B. Du; M. W. Li; H. C. Cao; J. F. Sheng 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

Hepatitis B virus (HBV) genotype and YMD

Hepatitis B virus (HBV) genotype and YMDD motif mutation profile among patients infected with HBV and untreated with lamivudine

✍ Samad Amini-Bavil-Olyaee; Sayed Younes Hosseini; Farzaneh Sabahi; Seyed-Moayed A 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 372 KB